Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Alok, Chaturvedi"'
Autor:
Chiradoni Thungappa Satheesh, Rakesh Taran, Jitendra Kumar Singh, Shanti Prakash Shrivastav, Nikunj K. Vithalani, Kalyan Kusum Mukherjee, Rajnish Vasant Nagarkar, Tanveer Maksud, Ajay Omprakash Mehta, Krishnan Srinivasan, Mummaneni Vikranth, Satish Ramkrishna Sonawane, Ateeq Ahmad, Saifuddin Sheikh, Shoukath M. Ali, Ronak Patel, Mahesh Paithankar, Lav Patel, Anil Rajani, Deepak Bunger, Alok Chaturvedi, Imran Ahmad
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: A novel nanosomal paclitaxel lipid suspension (NPLS), free from Cremophor EL (CrEL) and ethanol, was developed to address the solvent-related toxicities associated with conventional paclitaxel formulation. Objective: To evaluate the effic
Externí odkaz:
https://doaj.org/article/195a2e09073747269a55c7d3f9764a63
Autor:
Sonal Mehta, Alok Chaturvedi
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 17, Iss 5, Pp QC01-QC06 (2023)
Introduction: Progesterone is the treatment of choice for support of the luteal phase of controlled ovarian stimulation cycles in women undergoing an Assisted Reproductive Technology (ART) treatment. Available progesterone preparations include oral,
Externí odkaz:
https://doaj.org/article/1e3361dd5850404caf6061bd0131a5e1
Autor:
Shashikant Sharma, Vishali Gupta, Aniruddha Maiti, Sribhargava Natesh, Sandeep Saxena, Vivek Dave, Vimal Parmar, Raju Sampangi, Hemanth Murthy, Sandhya Dharwadkar, Naresh Kumar Yadav, Shrinivas Joshi, Rahul Mayor, Dhanashree Ratra, Soumyava Basu, Neha Goel, Alok Chaturvedi, Ronak Patel, Vinu Jose
Publikováno v:
International Journal of Retina and Vitreous, Vol 7, Iss 1, Pp 1-10 (2021)
Abstract Background Razumab™ (world’s first biosimilar ranibizumab) is approved for several macular disorders including wet age-related macular degeneration (AMD). We evaluated the safety and efficacy of biosimilar ranibizumab in wet AMD. Methods
Externí odkaz:
https://doaj.org/article/bb8509736af64a8799ac8af46ca70d15
Publikováno v:
Ophthalmology and Therapy, Vol 9, Iss 3, Pp 625-639 (2020)
Abstract Purpose The REal life assessmENt of safety And effeCTiveness of Razumab 2 (RE-ENACT 2) study evaluated the long-term effectiveness of biosimilar ranibizumab. We present the subgroup analysis of patients with retinal vein occlusion (RVO). Met
Externí odkaz:
https://doaj.org/article/b1682f44c5e64863837e5a1858953581
Publikováno v:
New Indian Journal of OBGYN, Vol 5, Iss 2, Pp 71-78 (2019)
Polycystic Ovarian Syndrome (PCOS) is one of the most common metabolic and reproductive ailment among reproductive age group women. PCOS patients present with a constellation of signs and symptoms associated with menstrual dysfunction and androgen ex
Externí odkaz:
https://doaj.org/article/eea70500c16646caa991822007327075
Autor:
Prasad Narayanan, Palanki Satya Dattatreya, Rammohan Prasanna, Sundaram Subramanian, Kunal Jain, Nirni Sharanabasappa Somanath, Nisarg Joshi, Deepak Bunger, Mujtaba Ali Khan, Alok Chaturvedi, Imran Ahmad
Publikováno v:
Sarcoma, Vol 2019 (2019)
Objective. To evaluate the efficacy and safety of nanosomal docetaxel lipid suspension (NDLS, DoceAqualip) based chemotherapy in patients with sarcoma. Methods. In this retrospective, multicenter (6 centers), observational study, we analyzed the medi
Externí odkaz:
https://doaj.org/article/49cc6e26ccd44413bd479e6b4f5704a7
Autor:
Revathi Badiginchala, Palanki Satya Dattatreya, Attili Venkata Satya Suresh, Sharanabasappa Somanath Nirni, Vindhya Vasini Andra, Deepak Bunger, Alok Chaturvedi
Publikováno v:
OncoTargets and Therapy.
Revathi Badiginchala,1 Palanki Satya Dattatreya,1 Attili Venkata Satya Suresh,1 Sharanabasappa Somanath Nirni,1 Vindhya Vasini Andra,1 Deepak Bunger,2 Alok Chaturvedi2 1Medical Oncology, Omega Hospitals, Hyderabad, Telangana, India; 2Medical Affairs,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::135f8e8583d94fac711f602a3f0c714f
https://www.dovepress.com/efficacy-and-safety-of-nanosomal-docetaxel-lipid-suspension-ndls-versu-peer-reviewed-fulltext-article-OTT
https://www.dovepress.com/efficacy-and-safety-of-nanosomal-docetaxel-lipid-suspension-ndls-versu-peer-reviewed-fulltext-article-OTT
Publikováno v:
IP International Journal of Orthopaedic Rheumatology. 7:93-100
Teriparatide (TPTD) (recombinant Parathyroid Hormone 1-34) is one of the pioneer osteo-anabolic agents approved for management of osteoporosis. Being an anabolic agent, it increases bone mineral density by inducing formation of new bone by the action
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18f08c06f46fb15acee345016b7a6bb5
https://doi.org/10.18231/j.ijor.2021.021
https://doi.org/10.18231/j.ijor.2021.021
Publikováno v:
Ophthalmology and Therapy
Ranibizumab is approved for the treatment of several macular disorders, including wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), retinal vein occlusion (RVO) and myopic choroidal neovascularization (mCNV), among others.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d8f6997a9a60aa1411c3690b329118a
http://europepmc.org/articles/PMC8216589
http://europepmc.org/articles/PMC8216589
Autor:
Saurabh Bhave, Gaurav Prakash, Dinesh Bhurani, Priyanka Samal, Shyam Aggarwal, Ghanashyam Biswas, Waseem Abbas, Vamshi Krishna, Venkatraman Radhakrishnan, Srinivas Chakravarthy Gummaraju, Radheshyam Naik, Chirag Shah, Sandip Shah, Parameswaran Anoop, Narendra Agrawal, Reena Nair, Ronak Patel, Shreekant Sharma, Anil Rajani, Deepak Bunger, Alok Chaturvedi
Publikováno v:
Blood. 140:12087-12088
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::740b80bc5f65e07d26d405042d355e51
https://doi.org/10.1182/blood-2022-158455
https://doi.org/10.1182/blood-2022-158455